|Partial Close, 12/2011 ||$725k|
|Partial Close, 7/2012 ||$355k|
|Grant, 6/2013 ||$4.3M|
Transposagen Biopharmaceuticals is a privately held biotechnology company that is dedicated to providing unique animal models of human diseases for drug discovery and development. Transposagen is currently focusing on the $1.2 billion/year rodent model market. The rodent model market is experiencing double digit annual growth due to the research and development needs of the pharmaceutical industry.